Tuesday 12th August 2008
0700 - 1800	Registration Desk Open
0715 - 0815	Early Morning Workshop 11 EMW11 Bayside Auditorium B	Early Morning Workshop 12 EMW12 Parkside Auditorium	Early Morning Workshop 13 EMW13 Bayside Auditorium A	Early Morning Workshop 14 EMW14 Bayside Room 102	Early Morning Workshop 15 EMW15 Parkside Ballroom B	Early Morning Workshop 16 EMW16 Parkside 110A	Early Morning Workshop 17 EMW17 Bayside Room 204 A & B	Early Morning Workshop 18 EMW18 Bayside Gallery	Early Morning Workshop 19 EMW19 Bayside Room 103	Early Morning Workshop 20 EMW20 Parkside 110 B	Early Morning Workshop 21 EMW21 Bayside Room 104
	Ethics - The Istanbul Declaration	Optimising Immunosuppressive Therapy with MMF	CMV Infection in Transplant Recipients: Clinical Clues and Prevention Strategies	Pathology of Pancreas Transplant Rejection	Practical and Clinical Implications of Co-Stimulation Blockade as a Means To Improve Outcomes in Transplantation	Islet Isolation - Quality Control and Imaging	Paired Kidney Exchange	Antibody Mediated Rejection	Clinical Xenotransplantation - A Status Report	New Onset Diabetes After Transplantation	Living Donor Liver Transplantation
	Chairs: Annika Tibell, Francis Delmonico	Chairs: Rowan Walker, Bryce Kiberd	Chairs: Camille Kotton, Carmel Hawley	Chairs: Cinthia Drachenberg, Alan Saunder	Chairs: Graeme Russ, Josep Grinyo, Klemens Budde	Chairs: Wayne Hawthorne, Hirohito Ichii	Chairs: Paolo Ferrari, Michael Rees	Chairs: Paul Trevillian, Patricia Campbell	Chairs: Robin Pierson, Megan Sykes	Chairs: Steven Chadban, Connie Davis	Chairs: Michael Crawford, Stephen Munn
0715	Introduction - Why, When and Where?	Drug Exposure for Mycophenolic Acid Derivatives - Is It Important?	Overview of CMV Infection in Transplantation	Rejection of Simultaneous Pancreas and Kidney Transplants	Welcome and Introductions	Predictive Methods for Assessing The Quality of Isolated Pancreatic Islets	Korean Experience with PKE	Can we Predict Who Will Get AMR?	Clinical Perspective: Organs	Introduction – Key Issues in NODAT Today	Donor and Recipient Selection
	Annika Tibell (Stockholm, Sweden)	Dirk Kuypers (Leuven, Belgium)	Atul Humar (Edmonton, Canada)	Diego Cantarovich (Nantes, France)	Graeme Russ (Adelaide, Australia)	Masafumi Goto (Sendai, Japan)	Die Joong Kim (Seoul, South Korea)	Denis Glotz (Paris, France)	Emanuele Cozzi (Padova, Italy)	Steven Chadban (Sydney, Australia)	Sheung Tat Fan (Hong Kong)
0730	Defining Transplant Tourism, Organ Trafficking and Transplant Commercialisation	Measuring Exposure of Mycophenolic Acid Derivatives - Is It Possible?	CMV Drug Resistance: Clinical Impact and Potential Strategies	The Role of Protocol Biopsies: What Can it Tell Us and Does it Matter?	Chronic Renal Allograft Dysfunction	Detection of Viable Beta Cells	Making PKE Work in the USA	Acute AMR - Current Treatment Strategies	Clinical Perspectives: Islets	Mechanisms and Potential to Minimise NODAT Through Immunosuppressant Management	LDLT for HCC in Japan
	Francis Delmonico (Boston, USA)	Teunis van Gelder (Rotterdam, The Netherlands)	Sunwen Chou (Portland, USA)	Alan Farney (Winston-Salem, USA)	Graeme Russ (Adelaide, Australia)	Sundararajan Jayaraman (Chicago, USA)	Michael Rees (Toledo, USA)	John Pirsch (Madison, USA)	Megan Sykes (Boston, USA)	Alan Jardine (Glasgow, Scotland)	Satoro Todo (Sapporo, Japan)
0745	Governing Principles and Compatible Practices - Deceased Donation	Measuring Exposure of Mycophenolic Acid Derivatives - Clinical Application	Discussion	The Role of the Histopathologist	The Importance of Renal Function on Graft and Patient Survival after Kidney Transplantation	The Role of FACS Analysis in QC	Ingredients of a Successful PKE Program	Chronic and Delayed Acute AMR - Current Treatment Strategies	WHO Perspective	Steroid freedom and other treatment strategies	LDLT – is it Justified?
	Mario Abbud-Filho (Sao Paolo, Brazil)	Yannick Le Meur (Brest, France)		John Papadimitriou (Baltimore, USA) and Julio Goldberg (Buenos Aires, Argentina)	Klemens Budde (Berlin, Germany)	Hirohito Ichii (Miami, USA)	Marry de Klerk (Rotterdam, The Netherlands)	Patricia Campbell (Edmonton, Canada)	Luc Noel (Geneva, Switzerland)	Connie Davis (Seattle, USA)	Russell Strong (Brisbane, Australia)
0800	Governing Principles and Compatible Practices - Living Donation	Discussion		Discussion	Practical Implications of Co-stimulation Blockade Therapy: Experience from the Belatacept Trials	Discussion	Discussion	Discussion	Discussion	Panel Discussion	Discussion
	Vivekanand Jha (Chandigarh, India)				Josep M. Grinyo (Barcelona, Spain)
					Panel Discussion
0830 - 1000	Plenary Session 2 PL02 Bayside Auditorium B
	Genomics and Proteomics - Will they Impact on Clinical Transplantation?
	Chairs: Richard Allen, Gerhard Opelz
0830	Genomics Will Alter Management of Early and Late Allograft Dysfunction?
	Philip Halloran (Edmonton, Canada)
0900	Proteomics Will Alter Clinical Practice?
	Peter Nickerson (Winnipeg, USA)
0930	Pharmacogenetics Will Determine Selection of Immunosuppression?
	Uwe Christians (Aurora, USA)
1000 - 1030	Morning Tea
1030 - 1200	Concurrent Oral Session 21 TO21 Bayside Auditorium B	Concurrent Oral Session 22 TO22 Parkside Auditorium	Concurrent Oral Session 23 TO23 Bayside Auditorium A	Concurrent Oral Session 24 TO24 Bayside Room 102	Concurrent Oral Session 25 TO25 Parkside Ballroom B	Concurrent Oral Session 26 TO26 Parkside 110A	Concurrent Oral Session 27 TO27 Bayside Room 204 A & B	Concurrent Oral Session 28 TO28 Bayside Gallery	Concurrent Oral Session 29 TO29 Bayside Room 103	Concurrent Oral Session 30 TO30 Parkside 110 B
	Late Breaking	Living Donor Liver Transplants	Liver Immunosuppression	Post Transplant Malignancy	Tolerance Induction Mechanisms	Stem Cells	Antibody and Complement	Allocation Policies	Paediatric Kidney/Heart Transplantation	Kidney Transplantation - Surgical Complications
	Chairs: Henrik Ekberg	Chairs: Juan Carlos Valdecasas, Robert Jones	Chairs: Steven Lynch, Stephen Munn	Chairs: John Stewart, Edward Geissler	Chairs: Thomas Pearson, Alex Bishop	Chairs: Kerry Atkinson, Katarina LeBlanc	Chairs: Christopher Parish, Steven Sacks	Chairs: Paul Robertson, Luc Delriviere	Chairs: Lorraine Bell, Mandeep Mehra	Chairs: Ron Shapiro, Christine Russell
1030	NFkB-decoy transfection into the donor kidney using a novel approach of ultrasound-Optizon mediated gene transfer technique' efficiently preventedacute rejection and prolonged animal survival in rat renal allografts	Combined Use Of Rituximab And Intra Portal Infusion Therapy For Adult Abo-Incompatible Living-Donor Liver Transplantation.	The Influence Of Induction Therapy On Graft And Patient Survival In Liver Transplant Patients With And Without Hepatitis C Using The Unos/Srtr Database	Immunosuppression For Primary Renal Disease And The Risk Of Cancer In Subsequent Renal Transplantation	Macrophages Driven To A Novel State Of Activation Promote T Cell Regulation And Organ Transplant Tolerance	Embryonic Stem Cell-Derived Cxcr4+ Definitive Endodermal Progenitor Cells Correct Factor Viii Deficiency In Mice	Specific Inhibitor Of Plasminogen Activator Inhibitor-1 Attenuates Myocardial Cell Infiltration And Graft Arterial Diseases In Murine Cardiac Allografts	Impact Of Donor Age, Donation After Cardiac Death, And Risk Of Disease Transmission On Rate Of Organs Transplanted Per Deceased Donor	A Minimal, Highly Specific And Sensitive Gene-Set For Peripheral Blood-Based Diagnosis And Prediction Of Acute Renal Transplant Rejection	The Benefit Of Single And Double Kidney Transplantation From Expanded Criteria Donors And Donation After Cardiac Death
	Azuma Haruhito	Minoru Tanabe	Dilip Moonka	Adrian Hibberd	Edward Geissler	Nicholas Zavazava	Jun-Ichi Suzuki	Kevin O'Connor	Lihua Ying	Junichiro Sageshima
1040	Long term survival and function of adult porcine islets co-transplanted with adult porcine Sertoli cells into rats without immunosuppression.	Complete Hilar Plate Looping In The Living Liver Donor Prevents Recipient Biliary Complications	Spare-The-Nephron (Stn) Trial In Liver Transplant Recipients: Interim Efficacy And Safety Of Mycophenolate Mofetil (Mmf)/Sirolimus (Srl) Maintenance Therapy After Cni Withdrawal	Immunosuppression Is A Risk Factor For Urinary Tract Cancers In Renal Transplant Recipients	Liver Sinusoidal Endothelial Cells Suppress Alloimmune Responses Via Mhc Class Recognition In Liver Transplantation	Hoxb4 Regulates Differentiation Of Hematopoietic Progenitor Cells From Embryonic Stem Cells	Plasma Lipids Infiltrate Arterial Allografts And Accelerate The Development Of Transplant Arteriosclerosis	Ten Years Of Non-Heart Beating Donation In The Netherlands Reviewed; Are We Better Off?	Calcineurin Inhibitors Are A Factor In The Unchanged Rate Of Renal Graft Loss Surviving More Than 5 Years: Evidence From The Anzdata Registry	Pre-Emptive Repeat Kidney Transplantation Is Associated With An Increased Risk Of Second Graft Loss In Patients With A Short Duration Of First Graft Survival.
	David White	Arvinder Soin	Dilip Moonka	Ting Hui, Angeline Goh	Masataka Banshodani	Nicholas Zavazava	Alexandru Schiopu	Hendrik Van Leiden	Jeffery Fletcher	Olwyn Johnston
1050	Virus-specific CD8+ T-cell function and protection from HCMV reactivation/disease in solid organ transplant patients	Inhibition Of Mitochondrial Biogenesis In Small-For-Size Liver Grafts	Hepatitis C (Hcv)- 3 Study: Does Immunosuppression (Is) Affect Hcv Recurrence (Hcvr) Progression After Liver Transplantation (Olt)?	Quantitating The Effect Of Immunosuppression On The Biologic Behavior Of Cancer	Liver Dendritic Cells Are Potent Inducers Of Regulatory T Cells And Liver Transplant Tolerance	Use Of Murine Mesenchymal Stem Cells To Express Donor-Derived Mhc Class Imolecules For Donor-Specific Immunosuppression.	Effect Of Probucol On Rejection Of Heart Allografts And Transplant Recipient Endothelial Function	Impact Of Legal Regulations In Organ Transplantation	Pediatric Living Donor Kidney Transplantation Using Alemtuzumab Pre-Conditioning And Tacrolimus Monotherapy	Anticoagulation After Renal Transplantation Prevents Graft Thrombosis In Patients With  Thrombophilia
	Tania Crough	Zhi Zhong	Goran Klintmalm	Jason Everly	Wei Li	Christian Graeb	Jerome Laurence	Gunter Kirste	Henkie Tan	Christine Hwang
1100	An Analysis of the List and Deaths among Candidates Waiting for a Kidney Transplant	Vanishing Graft Syndrome In Dual Living Donor Liver Transplantation	A Randomized, Open-Label, Comparative Evaluation Of Conversion From Calcineurin Inhibitors To Sirolimus Versus Continued Use Of Calcineurin Inhibitors In Liver Allograft Recipients	Currency Of Receipt Of Immunosuppressive Agents And Other Risk Factors For Lip Cancer Following Renal Transplantation	Cd25+Gitr+ Regulatory T Cells Play An Essential Role In Allograft Protection In Non-Lymphopenic Tolerised Primary Transplant Recipients	Prevent Remodeling And Repair Infarcted Myocardium By Autologous Intracoronary Mesenchymal Stem Cells Modified With Akt In Swines	Complete Inhibition Of Aortic Transplant Arteriosclerosis Without Immunosuppression By Manipulating Cd34+ Vascular Progenitor Cells To Promote Regenerative Repair.	Preliminary Results Of A Prospective Allocation Policy Of Expanded Criteria Donors (Ecd) Kidneys: Comparison Of Correlations Between A Clinical And Histopathological Scoring Systems With Outcomes.	Kidney Transplantation In Children And Adolesents - Analysis Of Optn/Unos Data	A Systematic Approach To Minimizing Wound Problems For De Novo Sirolimus Treated Kidney Recipients
	Francis Delmonico	Gi-Won Song	Chung Mau Lo	Marina van Leeuwen	Andrew Bushell	Zhenya Shen	Anthony Dorling	Luis Santiago Re	Yong Cho	Stuart Flechner
1110	Pregnancy After Kidney Donation	Right Hepatic Lobe And Kidney Transplantation From The Same Living Donor: 5Cases Including 1 Abo-Incompatible	Steroid-Free Immunosuppression In Liver Recipients Comparing Tacrolimus Monotherapy After Daclizumab Induction Versus Tacrolimus And Mmf – The Marsilea Study	Twenty Year Cancer Outcomes Of A Randomised Trial Of Immunosuppression In Kidney Transplant Recipients: Results Of The Australian Multicentre Trial Of Cyclosporine Withdrawal	The Powerful T-Cell Tolerizing Consequences Of Blocking Expression Of Pro-, Not Anti-Inflammatory Mechanism	Mesenchymal Stromal Cells In Renal Transplantation: Migration And Immunomodulation	Modulation Of Ischemia Reperfusion Injury By The Nano Particle Delivery Of C3Specific Small Interfering Rna (Sirna)	Consequences Of Allocating Deceased Donor Organs Based On Recipient Antibody Specificities (Cpra)	Outcomes Of Paediatric Kidney Transplants After Switch To Sirolimus.	An Observational Multicenter Spanish Study Of Surgical Complications After Kidney Transplantation In The New Era Of Immunosuppression
	Hassan Ibrahim	Serguei Gautier	Gerd M. Otto	Martin Gallagher	Maria Koulmanda	Steven McTaggart	Marie Parker	Ronald Kerman	Sean Kennedy	Julio Pascual
1120	Using Voclosporin Pharmacokinetics (Concentration) and Pharmacodynamics (Calcineurin Activity) to Predict Optimum Immunosuppression in a Phase 2b Renal Transplantation Trial	Older Age And Right Hepatectomy Are Associated With Increased Risk Of Intraoperative Complications During Donor Hepatectomy In Living-Donor Liver Transplantation	Benefit Of Mycophenolate Mofetil, Delayed And Reduced Tacrolimus And Daclizumabin De Novo Liver Transplantation – Results From The Per Protocol Population At12 Months	The Effect Of Conversion To Sirolimus On Immune Phenotype In Transplant Recipients With Cutaneous Squamous Cell Carcinoma	Divergent Role Of Tissue/Donor Dendritic Cells In Rejection Versus Tolerance Of Cardiac Allografts: Studies With Cx3Cr1-Deficient And B6.Fvb-Tg (Itgax-Dtr/Egfp)57 Mice	Hepatic Stellate Cells More Effectively Protect Islet Allografts Than Bone Marrow-Derived Mesenchymal Stem Cells	Elicited Antibody Responses To Igb3 Glycolipid Is Dependent On A Novel Pathway	Informing Organ Allocation Policy: Defining Equitable And Utility-Based Age Cut-Offs For Donor And Recipient Age Matching	Extended Enrolment And Analysis Of A Prospective Steroid-Free Immunosuppression Trial Supports Study Safety And Efficacy	Diagnosis And Significance Of Transplant Renal Artery Stenosis
	Herwig-Ulf Meier-Kriesche	Adnan Torgay	A. David Mayer	Robert Carroll	Rex Smith	Horng-Ren Yang	Mauro Sandrin	John Gill	Minnie Sarwal	Richard Allen
1130	Renal function, efficacy and safety of Everolimus (RAD) / Enteric-coated Mycophenolate Sodium (EC-MPS) therapy after Calcineurin inhibitor (CNI)withdrawal in de novo renal transplant patients: Final outcomes of the ZEUSstudy	Laparoscopic Hepatectomy For A Modified Right Graft In Adult-To-Adult Living Donor Liver Transplantation	Everolimus Is Effective And Safe In A Six-Month, Randomized, Multicenter Conversion Trial In Maintenance Liver Transplant Recipients	Impact Of Kidney Transplantation And Cancer Comorbidity Compared With Cancer Alone On Expected Survival: A Registry Analysis From Australia And New Zealand.	Caspase Inhibitor Therapy Synergizes With Costimulation Blockade To Promote Tolerance Induction And Prevent Allosensitization In Islet Transplantation.	Hepatocyte Based Insulin Gene Therapy	Induction Of Renal Allograft Accommodation In Donor Skin-Presensitized Nonhuman Primates By Short-Term Inhibition Of Circulating Complement	The Impact Of A New Kidney Allocation Scheme In The Uk	Twenty Year Outcomes After Heart Transplantation During Infancy	Renal Transplantation In The Morbidly Obese
	Klemens Budde	Joohyun Kim	Herold Metselaar	Angela Webster	Juliet Emamaullee	Hans Sollinger	Gang Chen	Chris Rudge	Richard Chinnock	William Bennett
1140	Cost-Effectiveness of Hypothermic Machine Perfusion versus Static Cold Storagein Kidney Transplantation: First Results of the Prospective European RCT	Adult-To-Adult Living Donor Liver Transplantation Using Extended Right Lobe Liver Grafts	Strategy For Tailoring Minimal Immunosurppression After Living Donor Liver Transplantation : Predictive Algorithm Based On Multi Parameter Mixed Lymphocyte Reaction Assay Using Cfse-Labeling Technique.	Impact Of Cancer On Survival After Kidney Transplantation	Combination Of Anti-Lfa-1 And Anti-Cd154 Monoclonal Antibodies Induces Tissue-Specific Tolerance To Neonatal Porcine Islet Xenografts	Complete Reversal Of Stz Induced Diabetes Using Adult Pdpc Cells	One Possible Mechanism Of Antibody Mediated, Complement Independent Transplant Arteriopathy In Mice	Effect Of Donor Ethnicity On Kidney Survival In Different Recipient Ethnicity -An Analysis Of Optn/Unos Database	Everolimus In Pediatric Heart Transplantation: First Report On Routine Clinical Use In Infants Below The Age Of 9 Months	Weight Gain In The First Year After Kidney Transplantation
	Rutger Ploeg	KI HUN KIM	Yuka Tanaka	Angela Webster	Hossein Arefanian	Paul Shiels	Tsutomu Hirohashi	Clive Callender	Elke Lehmkuhl	Diane Steffick
1150	Comparison of an initially intensified dosing regimen versus a standard dosingregimen of enteric-coated mycophenolate sodium (EC-MPS) in renal transplantpatients: Efficacy and safety analysis of 75 patients		Tacrolimus Monotherapy In Liver Transplantation: One-Year Results Of A Prospective, Randomized, Double-Blind Placebo-Controlled Study	Sequential Treatment With Rituximab And Chop Chemotherapy In B-Cell Ptld – Will Risk Stratified Treatment Become The New Standard In Therapy?	Targeting Of Costimulation Blockade Resistant T - Effector Memory (Tem) Cells Innon-Human Primate Renal Transplantation With Lfa-3-Ig (Alefacept) Prolongs Allograft Survival		Value Of Foxp3 Mrna In Peripheral Blood As Rejection Marker After Miniature Swine Lung Transplantation.	Influence Of Donor Type On Elderly Kidney Transplant Survival And Allograft Function		Mortality-Predictability Of Body Mass Index (Bmi) In Transplant-Wait-Listed Maintenance Hemodialysis Patients: A 5-Year National Cohort Study
	Wolfgang Arns		Jan Lerut	Ralf Trappe	Allan Kirk		Naoki Satoda	Luke Shen		Kamyar Kalantar-Zadeh
1230 - 1330	Lunch
1200 - 1300	Poster Session 2
1200 - 1300	Mini-Oral Session 9 TMO09 Hall 6 Presentation Booth 1	Mini-Oral Session 10 TMO10 Hall 6 Presentation Booth 2	Mini-Oral Session 11 TMO11 Hall 6 Presentation Booth 3	Mini-Oral Session 12 TMO12 Hall 6 Presentation Booth 4	Mini-Oral Session 13 TMO13 Hall 6 Presentation Booth 5	Mini-Oral Session 14 TMO14 Hall 6 Presentation Booth 6	Mini-Oral Session 15 TMO15 Hall 6 Presentation Booth 7	Mini-Oral Session 16 TMO16 Hall 6 Presentation Booth 8
	Renal 3: Living Donors	Immunosuppression 2 - Liver and Lung	Infectious Diseases 1: Bacterial, Fungal and Other Infections	Immunobiology 2: Tolerance and Rejection	Renal 4 - Surgical Complications	Islets	Organ Donation and Ethics	Cardiothoracic
	Chairs: Amanda Robertson, Faissal Shaheen	Chairs: Robert Brown, Peter Barclay	Chairs: George John, Michael Falk	Chairs: Maria Koulmanda, Shane Grey	Chairs: Peter Horton, Albert Shun	Chairs: Silviu Itescu, Rodolfo Alejandro	Chairs: Monda Al-Rukhaimi, Tomonori Hasegawa	Chairs: Heather Ross, Christopher Hayward
1200	Metabolic Syndrome Components Before Living Kidney Donation And Long-Term Renal Function Outcome For The Donors	Campath-1H (C1H) Induction In Adult Liver Transplantation: Six Years Experience Of A Single Center.	Impact Of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Urinary Tract Infection In Kidney Transplant Patients	Pivotal Role Of The Natural Killer T Cell For The Induction Of Mixed Chimerism In The Thymus	Minimally Invasive Video-Assisted Kidney Transplantation (Mivakt)	Combined Islet And Hematopoietic Stem Cell Allotransplantation: A Clinical Pilot Trial To Induce Chimerism And Graft Tolerance	Converting The Potential For Donation After Cardiac Death Into Actual Donors: A Comparison Between Belgium And The U.K.	Donor High Risk Social Behavior And Outcomes In Cardiac Transplantation
	Josefina Alberu	Panagiotis Tryphonopoulos	Man-Fai Lam	Tatsushi Onzuka	SEONG PYO MUN	Davide Mineo	Leo Roels	Alexis Shafii
1205	Correlation Of Renal Functional Measurements And Implantation Biopsies With Outcomes In Living Donor Renal Transplantation	Conversion To Enteric-Coated Mycophenlate Sodium (Ec-Mps) From Mycophenolate Mofetil (Mmf) In Stable Liver Transplant Recipients – Comparison Of Phramacokinetics (Pk) And Gastrointestinal Disturbances	Pneumonia In Solid Organ Recipients: Review Of 217 Episodes	Requirement Of The Thymus For Breaking Tolerance To Renal Allografts Via The Indirect Pathway	Additional Vascular Reconstruction And Special Vascular Anastomotic Techniques –An Impact Factor In Early Graft Dysfunction?	Kidney Function After Clinical Islet Transplantation	Evaluating The Non-Heart-Beating Donor (Nhbds) Potential In A Large Level-Three University Hospital In China And Donation-Related Issue	The Effect Of Recipient Hepatitis C Virus Infection On Outcomes Following Heart Transplantation.
	Tracy Tan	Tomoaki Kato	Hugo Bonatti	Kazuhiko Yamada	MARCIAN  ANTONIO MANU	Cristiane Leitao	Bin Zhu	Alexis Shafii
1210	Long-Term Risk Of Hypertension And Renal Dysfunction In Living Kidney Donors	Early Immunosuppression Weaning After Cadaver Liver Transplantation Using Atg Induction And Rapamycin	Changing Patterns Of Candidaemia Following Solid Organ Transplantation In The Era Of Antifungal Prophylaxis: The Australian Experience.	Increased Production Of The Regulatory T-Cell Transcription Factor Fox P-3 M-Rnain Campath-1H And  Donor Hematopoetic Stem Cell Treated Kidney Transplant Recipients	Evaluation Of Influence Of Nephrectomy Before And After Kidney Transplantation On Complication Incidence In Patients With Esrf In The Course Of Adpkd	Hypoxia Inducible Factor 1Alpha (Hif-1Alpha) Is Required For Successful Islet Transplantation And Increasing Hif-1Alpha With Desferrioxamine Markedly Improves Outcomes	Rescue Allocation For Liver Transplantation Within Eurotransplant: Results Of A Single Center Experience	Influence Of Abo-Compatible Transplantation On Long-Term Outcome In Cardiac Transplant Recipients
	Hyeon Seok Hwang	Alexis Buggenhout	Sebastiaan Van Hal	Robert Cirocco	Tadeusz Sulikowski	Rebecca Stokes	Arash Nickkholgh	Arezu Aliabadi
1215	Are We Taking A Proper Care Of The Living Donors? A Follow – Up Study Of Living Kidney Donors In Poland And Further Management Proposal	Pharmacokinetics (Pk) Of Tacrolimus For A Once Daily Prolonged Release Formulation (Advagraf®) Versus Twice-Daily (Prograf®) In De Novo Liver Transplant Recipients In A Phase Iii Multicentre Study	Pulmonary Aspergillosis After Solid Organ Transplantation: Diagnosis And Treatment Based On Single Center Experiences For 28 Years	Comparison Of Lung And Kidney Allografts In Induction Of Tolerance By Amixed-Chimerism Approach In Cynomolgus Monkeys	Perioperative Anticoagulation And Antiplatelet Therapy In Renal Transplant: Is There An Increase In Bleeding Complication?	New Pancreas Preservation Strategy For Successful Clinical Islet Transplantation	Utility Of Polycystic Kidneys From Deceased Donors For Renal Transplantation	Effect Of Donor Gender On Graft Survival Following Orthotopic Heart Transplantation
	Wojciech Rowinski	Nasrullah Undre	Kyu Ha Huh	Akihiro Aoyama	Michael Marvin	Masayuki Shimoda	Handoo Rhee	Elke Lehmkuhl
1220	Longitudinal Study On Renal Effects Of Changes In Body Weight After Living Kidney Donation: Weight Gain Burdens The Remnant Kidney	Calcineurin Inhibitor (Cni) Withdrawal In Adult Liver Transplant Recipients: An Analysis Of Long Term Efficacy	Pre-Emptive Valganciclovir Therapy Is Not Associated With Increase Incytomegalovirus (Cmv) Dna In Renal Allograft Biopsy Specimens Compared With Valacyclovir Prophylaxis	Different Foxp3 Expressing Regulatory T Cells In The Liver Contribute To Portal Tolerance	Coagulopathy Associated With Thymoglobulin Induction Therapy Following Renal Transplantation	Islet Transplantation For Brittle Type 1 Diabetes: The Uic Protocol	Dual Vs. Single Kidney Transplants In The Eurotransplant Senior Program	Standard In Surveillance End Myocardial Biopsy (Emb) Protocol  In The First Month After Heart Transplantation: Time For A Reappraisal?
	Mieneke Rook	Julie Thompson	Tomas Reischig	Wei Li	Michael Gallichio	Antonio Gangemi	Axel Rahmel	Chiara D'Agostino
1225	Evaluating Potential Living Kidney Donors By Renal Function Equations Leads To Unnecessary Reduction Of The Donor Pool	Monitoring Virus Specific T Cells May Improve The Management Of Immunosuppression After Liver Transplantation	Ptld Derived Tumor Variants Of Ebv Latent Membrane Protein 1 Induce Sustained Erk Activation And Cfos Induction	Cd4+Cd25+ Regulatory T Cells Combined With Low-Dose Sirolimus, But Not Calcineurin Inhibitors, Preserves Suppressive Function Of Regulatory T Cells And Prolongs Heart Allograft Survival In Mice	The Influence Of Kidney Vessel Resistance For Functioning Graft In The First Three Months After Transplantation.	Composite Islet-Kidneys Reverse Diabetes And Renal Failure Across A Fully Allogeneic Barrier In Nonhuman Primates	Organ Procurement After Euthanasia Procedure	Anemia Is A Risk Factor For Survival After Cardiac Transplantation
	Mieneke Rook	Richard Olsson	Olivia Martinez	Anlun Ma	Maciej Nowacki	Yoshinori Ishikawa	Dirk Ysebaert	Arezu Aliabadi
1230	Compensatory Increase In Gfr Up To 10 Years After Renal Donation	Long Term Calcineurin Sparing With Daclizumab Used In An Outpatient Liver Transplant Clinic	Wu And Ki Polyomaviruses – New Respiratory Viruses In Adult Hsct Recipients	Involvement Of Pdcs In The Tolerogenic Function Of Cd8+Cd45Rclow Treg Aftercd40-Cd40L Blockade In A Rat Heart Allotransplantation Model	Single Or Double Arteries In Kidney Donors: Influence On The Donor Long-Term Outcome	B Lymphocyte Dependent Rejection Of Islet Allografts Via Indirect Recognition In Autoimmune-Prone Nod Mice	Kidney Transplant Listing Following, Liver, Heart And Lung Transplantation	Regulators Of Complement Activation In Multiparous Vs. Nulliparous Heart Transplant Recipients.
	Ulla Berg	Gregory Smallwood	Patricia Ferguson	Xian Liang LI	Madeleine Nilsson	Ronald G. Gill	Titte Srinivas	E. Rene Rodriguez
1235	Effect Of Pre-Donation Blood Pressure, Gfr And Proteinuria On Their Post-Donation Levels	A Three Year Follow-Up Study Of Stable Liver Transplant Recipients Converted From Twice Daily Prograf® To Once Daily Advagraf (Extended Release Tacrolimus)	Tuberculosis And Transplantation	Allograft Tolerance Mediating Cd4+T Cells Depend Upon Interleukin-5 (Il-5), Notil-4.	Complications Of Overseas Kidney Transplantation : Kangnam St.Mary'S Hospital Experience	Quantifying Pancreatic Beta-Cell Regeneration	Approach To Solve Organ Shortage In Japan; From Perspective Of Coordinators Of Intrinsic Motivation	Microvasculopathy Does Not Affect The Favorable Outcome In Female Heart Transplant Recipients
	Adib Rizvi	Roy First	Monika Lindemann	Bruce Hall	Bok Jin Hyoung	Eric Grossman	Yoko Uryuhara	Nicola Hiemann
1240	Is Laparoscopic Donor Nephrectomy Really The Way Ahead?	Mtor  Inhibitors (Mtor-I) And Lung Transplantation: Can Its Use Be Justified?		Regulatory T Cells Infiltrate The Transplanted Skin Of Rats Induced To Accept A Hind-Limb Allotransplant	Risk Factors For Transplant Renal Artery Stenosis	Donor Pre-Treatment With A Novel Nf-Kb Inhibitor, Dhmeq Can Alleviate The Graft Damage In Syngenic Marginal Islet Transplantation		The Expression Of Chromogranin A In Dilated Cardiomyopathy And Its Relationship With Myocardial Fibrosis
	Sandeep Guleria	Piedad Ussetti		Suzanne Illdstad	Munish Heer	Tohru Takahashi		Ruizhen Chen
1245	Is Laparoscopic Donor Nephrectomy Really The Way Ahead?	Pronostic Factor For Mtor Inhibitors (Mtor-I) Proteinuria After Lung Transplantation			Occlusion Of Polar/Small Renal Transplant Arteries Should Not Be Misdiagnosed As Acute Rejection	Local Expression Of B7-H4 By Transducing Recombinant Adenovirus In Islet Grafts Inhibits Allotransplant Rejection		The Relationship Between Enterovirus Infection And Expression Of Chemokines In Myocardium Of Dilated Cardiomyopathy With Orthotopic Cardiac Transplantation
		Piedad Ussetti			Arunthathi Oormila Mahendran	Xiaojie Wang		Ruizhen Chen
1250		Outcome Of Patients Receiving Tacrolimus After Lung Lung/Heart Transplantation –One Center Experience.			Urological Complications: Analysis And Management Of 1525 Consecutive Renal Transplantations	Inhibiting Dipeptidyl Peptidase Iv Activity Improves Human Islet Graft Function In Immunodeficient Mice With Diabetes
		Cecilia Chaparro			Nikolaos Karidis	Huimin Yi
1255		Descriptive Analysis Of Pulmonary Transplant Patients, After Mycophenolate Mofetil To Enteric-Coated Mycophenolate Sodium Conversion Treatment.				Increased Total Insulin Content And Restoration Of First-Phase Insulin Secretion In Standardized Small Human Pseudo Islets
		Amparo Solé				Alessandro Faenza
	Novartis Sponsored Symposium
1200 - 1330	Optimising MPA Treatment - An Opportunity to Improve Long-Term Outcomes After Kidney Transplant Bayside Grand Hall
	Chairs: Klemens Budde, Rowan Walker
1200	Introduction
	K. Budde
1215	EC-MPS - Providing efficacy and safety for optimal treatment
	H. Sollinger
1235	Dosing - The foundation of optimal MPA Treatment
	W. Arns
1255	Improving long-term outcomes- a clinical reality with optimised MPA
	K .Budde
1315	Summary and Close
	R. Walker
1330 - 1500	State-of-the-Art Symposium Concurrent Session 11 STA11 Bayside Auditorium B	State-of-the-Art Symposium Concurrent Session 12 STA12 Parkside Auditorium	State-of-the-Art Symposium Concurrent Session 13 STA13 Bayside Auditorium A	State-of-the-Art Symposium Concurrent Session 14 STA14 Bayside 102	State-of-the-Art Symposium Concurrent Session 15 STA15 Parkside Ballroom B	State-of-the-Art Symposium Concurrent Session 16 STA16 Parkside 110A	State-of-the-Art Symposium Concurrent Session 17 STA17 Bayside 204 A&B	State-of-the-Art Symposium Concurrent Session 18 STA18 Bayside Gallery	State-of-the-Art Symposium Concurrent Session 19 STA19 Bayside 103	State-of-the-Art Symposium Concurrent Session 20 STA20 Parkside 110B
	Overcoming HLA and ABO antibodies	Liver Malignancy and Liver Transplantation	New Immunosuppressive Drugs in Development	Chronic Rejection/Allograft Dysfunction	Manipulating Regulatory Pathways to Control the Immune Response	Overcoming the Impediments to Long Term Islet Graft Survival	Advances in Organ Procurement	Paediatrics: Maximising long term graft survival	Intestinal Transplantation Update on an Emerging Therapy	Separating Graft Versus Host from Graft Versus Malignancy
	Chairs: Kazunari Tanabe, Douglas Norman	Chairs: Frederico Villamil, John Fung	Chairs: Barbara Murphy, Barry Kahan	Chairs: Andreas Zuckermann, John Wallwork	Chairs: Andrew Lew, Jerzy Kupiec-Weglinski	Chairs: Thomas Loudovaris, Olle Korsgren	Chairs: Marti Manyalich, Timothy Mathew	Chairs: Rulan Parekh, Andrew Rosenberg	Chairs: Andreas Tzakis, Adrian Hibberd	Chairs: David Sachs, Ken Bradstock
1330	Desensitisation - What Are the Important Components of Therapy?	Can You Go Outside Set Criteria for HCC?	With So Many Targets Why So Few New Agents?	(Emerging) Role of Antibody in Chronic Rejection	Identifying Human Tregs in Health and Disease	Issues and Strategies in Overcoming Early Graft Destruction	Expanding Opportunities for Donation in the US	Withdrawing Immunosuppression:  Safe for the Patient?  Safe for the Graft?	Indications, Immunosuppression and Results of Intestinal and Multivisceral Transplants	Adoptive Transfer of Antigen-Specific T Cells for Treatment of Malignancy and Opportunistic Infection After BMT
	Norio Yoshimura (Kyoto, Japan)	Francis Yao (San Francisco, USA)	Randall Morris (Basel, Switzerland)	Marlene Rose (Harefield, UK)	Barbara Fazekas De St. Groth (Sydney, Australia)	Olle Korsgren (Uppsala, Sweden)	Howard Nathan (Philadelphia, USA)	Sandy Feng (San Francisco, USA)	Geoffrey Bond (Pittsburgh, USA)	David Gottlieb (Sydney, Australia)
1400	Role and Effectiveness of Rituximab and IVIG in Desensitisation Protocols	Treatment on the Waiting List - Does it Alter Outcomes? (incl Salvage Transplant vs Resect and List)	Jak/Stat Inhibitors and Their Potential for Preventing Rejection	Role of the Microvasculature in Chronic Heart and Lung Allograft Dysfunction	T regs: Factors/Pathways Involved in Treg Function	Causes and Solutions to Long Term Graft Loss	Ex-Vivo Organ Management - Role of Machine Perfusion & New Solutions	Prevention of Chronic Injury to the Allograf	Monitoring and Techniques in Intestinal/Multivisceral Transplantation	Cytokine Dependent Manipulation of GVHD and GVL Responses
	Mark Pescovitz (Indianapolis, USA)	Juan Carlos Garcia-Valdecases (Barcelona, Spain)	John O'Shea (Bethesda, USA)	Martin Goddard (Cambridge, UK)	Nicholas Jones (Oxford, UK)	Jose Oberholzer (Chicago, USA)	Rutger Ploeg (Groningen, The Netherlands)	Patricia Birk (Winnipeg, Canada)	Andreas Tzakis (Miami, USA)	Geoffrey Hill (Brisbane, Australia)
1430	The Graft Is In But What Are the Long Term Outcomes and How Can They be Improved?	Genomics and HCC - Can it Predict Outcomes?	New Monoclonal Antibodies for Preventing Allograft Rejection: Anti-CD40 and Anti-LFA-1 mAb	Non-Immune Factors in BOS	Epigenetic Regulation of Foxp3 as a New Approach to Allograft Tolerance	What is the Optimal Immunosuppression for Islet Transplantation?	Special Aspects of Management for Extended Criteria Donors	Minimising Immunosuppression in the Transplant Patient	Highlights of the Meeting of the ITA	Antigen Presenting Cells in GVHD/GVL
	Robert Montgomery (Baltimore, USA)	Sheung-Tat Fan (Hong Kong)	Allan Kirk (Atlanta, USA)	Peter Hopkins (Brisbane, Australia)	Wayne Hancock (Philadelphia, USA)	Bruce Kaplan (Chicago, USA)	James Wynn (Augusta, USA)	Minnie Sarwal (Stanford, USA)	Douglas Farmer (Los Angeles, USA)	Megan Sykes (Boston, USA)
1500 - 1530	Afternoon Tea
1530 - 1700	Concurrent Oral Session 31 TO31 Bayside Auditorium B	Concurrent Oral Session 32 TO32 Parkside Auditorium	Concurrent Oral Session 33 TO33 Bayside Auditorium A	Concurrent Oral Session 34 TO34 Bayside Room 102	Concurrent Oral Session 35 TO35 Parkside Ballroom B	Concurrent Oral Session 36 TO36 Parkside 110A	Concurrent Oral Session 37 TO37 Bayside Room 204 A & B	Concurrent Oral Session 38 TO38 Bayside Gallery	Concurrent Oral Session 39 TO39 Bayside Room 103	Concurrent Oral Session 40 TO40 Parkside 110 B
	Highly Sensitised and ABOi Renal Transplantation	Liver Donor Allocation	Everolimus and Sirolimus in Renal Transplantation	Haemopoetic Cell Transplantation	Experimental Immunosuppression	Clinical and Experimental Lung Transplantation	Long-term Outcomes in Renal Transplantation	Ischaemia - Reperfusion Injury	Paediatric Liver Transplantation	Dendritic Cells and Costimulation
	Chairs: Norio Yoshimura, James Wynn	Chairs: Simone Strasser, Stephen Munn	Chairs: Franco Critterio, Jose Medina-Pestano	Chairs: Geoffrey Hill	Chairs: Jean-Paul Soullilou, Randall Morris	Chairs: Peter Hopkins, Gregory Snell	Chairs: Hallvard Holdaas	Chairs: Peter Cowan, Douglas Hanto	Chairs: Sandy Feng, Winita Hardikar	Chairs: Toby Coates, Angus Thomson
1530	Abo-Incompatible Kidney Transplantation Japanese Experience Of More Than 1,000Cases Since 1989\	Donation After Cardiac Death Liver Transplantation Does Not Influence Early Hepatitis C Recurrence Or Outcomes	A Randomized, Open-Label Study To Compare The Safety And Efficacy Of Two Different Sirolimus (Srl) Regimens With Tacrolimus (Tac) + Mycophenolate Mofetil (Mmf) In De Novo Renal Allograft Recipients: Preliminary 2-Year Safety Results From The Orion Trial	Soluble Lymphotoxin Plays A Critical Role In Graft-Versus-Host Disease.	Cardiac Allograft Vasculopathy In Cyclosporine-Treated Monkeys Depleted Of Cd20B-Cells	Living-Donor Lobar Lung Transplantation For Pulmonary Complications After Bone Marrow Transplantation	Forty Years Experience Of Pregnancies Among Kidney Transplant  Women; Pregnancy, Maternal And Graft Outcomes From The Australian And New Zealand Dialysis And Transplant Registry	Donor Dopamine For The Prevention Of Delayed Graft Function After Renal Transplantation: A Randomized Controlled Trial	Outcomes Of Liver Transplantation For Unresectable Malignant Liver Tumors In Children: A Multicenter Review	The Role Of The Pd-L1 Signal In The Regulation Of Allogeneic Immune Response
	Kota Takahashi	Rolf Barth	Stuart Flechner	Kate Markey	Richard Pierson	Masaomi Yamane	Vicki Levidiotis	Peter Schnuelle	Michelle Nadler	Wei Li
1540	Comparative Study Of Long-Term Outcomes Between Abo Incompatible And Compatible Living Donor Kidney Transplantation.	Expanding Donor Pool Using Steatotic Liver Grafts	Cardiovascular Risk Profile Of Renal Transplant Recipients Enrolled In An Open-Label, Randomized Study Comparing 2 Sirolimus (Srl) Regimens With A Tacrolimus (Tac) + Mycophenolate Regimen (Mmf): Preliminary Results From The Orion Trial	Cd154 Blockade Impairs Generation Of Cd8+ Cd44High/Cd62Llow/- Effector/Memoryt-Cells Induced By Both Alloantigen Exposure And Lymphopenia And Results In Prevention Of Sensitization	Inhibitory Effects Of Atacicept (Taci-Ig) On Circulating Antibodies, B Cells And Plasma Cells In Allosensitized Cynomolgus Monkeys	Association Between Donor Mbl Promoter Haplotype And Graft Survival And The Development Of Bos After Lung Transplantation	New Horizon For Older Patients With Esrd.Ecd Pre-Emptive Renal Transplantation Offers The Same Live Expectancy As The Standard Criteria Donor (Scd) Kidney Transplantation On Dialysis.	The Impact Of Purinergic Signalling In Renal Ischaemia-Reperfusion Injury	Does Living Donation Offer An Advantage In Survival After Pediatric Liver Transplantation In The Meld Era? - Analysis Of Optn/Unos Data	Costimulatory Blockade-Mediated Lung Allograft Acceptance Is Associated With Intra-Graft Accumulation Of Cd4+Foxp3+ Regulatory T Cells And Is Abrogated By Overexpression Of Bcl-2 In The Recipient
	Atsushi Aikawa	HUDA NOUJAIM	Graeme Russ	Suzanne Illdstad	Neal Smith	Janna Munster	Lloyd Ratner	BO LU	Yong Cho	Mikio Okazaki
1550	Elimination Of Splenectomy And Anti-Cd20 Therapy Does Not Result In Increased Chronic Allograft Nephropathy:  A Single Center Experience In Abo-Incompatiblerenal Transplantation	Liver Transplantation From Controlled Non-Heart Beating Donors: A Single Center Experience Of 20 Years Follow-Up	A Randomized, Open-Label Study To Compare The Safety And Efficacy Of Cyclosporine (Csa) Dose Reduction With Csa Elimination In De Novo Renal Allograft Patients Receiving Sirolimus	Segregation Of A Graft-Verssus-Leukemia Effect From Graft-Versus-Host Disease By The Modulation Of Donor Cd8+ T Cell Activity	Impact Of Immunosuppression On Uv-Induced Skin-Tumors In Mice: Rapamycin Impairs Tumor Outgrowth And Shifts The Mutation Types In The P53 Gene	Should Lung Transplant Recipients Routinely Perform Airway Clearance Techniques? A Randomised Controlled Trial	Estimated Gfr After Treatment Of Acute Rejection: A Surrogate Marker For Long-Term Graft Survival After Kidney Transplantation	Epo And Asialo Epo Protect Intestinal Ischemia Reperfusion Injury In Rat	Outcome Of Non-Heart Beating Donor (Nhbd) Livers In Paediatric Recipients.	Antigen Presentation By Epidermal Langerhans Cells Induces Cd4 T Cell Tolerance In Vivo
	Jayme Locke	Shinji Yamamoto	Helio Tedesco-Silva	Hong Rae Cho	Gudrun Koehl	Greg Snell	Marcelo Cantarovich	Tokihiko Sawada	Adam Bartlett	Elena Shklovskaya
1600	Rituximab Therapy Decreases Acute Rejection Rates Among Sensitized Renal Allograft Recipients	Outcomes Of Liver Allografts From Deceased Donors With A History Of Major Abdominal Trauma	Exposure To Everolimus, And Not To Cyclosporine, Is Associated With Freedom From Acute Rejection In De Novo Renal Recipients	Alloreactivity Of Human T Cells Is Associated To A High Level Of Cd45Rcexpression: Therapeutic Prospects For Hematopoietic Stem Cell Transplantation	Generating Effective Local Immunosuppression : Protection Of Islet Allografts Without Compromising Systemic Immunity	Lung Transplantation In Recipients 70 Years Of Age And Older	Tricontinental Analyses Of Kidney Transplant Outcomes From Three National Registries	Donor Pre-Treatment With An Hif-Pprolylhydroxylase-Inhibitor Improves Function And Increases Long-Term Graft Survival In An Allogenic Rat Transplant Model	Efficacy And Safety Of Cytomegalovirus Pp65 Antigenemia-Guided Preemptive Therapy In Pediatric Liver Transplant Recipients	Exosomes Captured, Processed And Exchanged By Splenic Dendritic Cells Spread Allo - Peptide Between Dcs And Amplify Anti Donor T Cell Response In Vivo.
	Manikkam Suthanthiran	Deborah Verran	Giuseppe Corbetta	Laurence Ordonez	Sarah Londrigan	Yoshiya Toyoda	Robert Merion	Michael Wiesener	Andrea De Icaza-González	Angela Montecalvo
1610	Clinical Significance Of B-Cell Positive Crossmatches And Luminex® Defined Donor-Specific Antibodies In Well-Matched Highly Sensitized Patients From The Australian Interstate Exchange	Domino Liver Transplantation (Lt) In Children And Adults With Maple Syrup Urine Disease (Msud)	Targeting Upper Everolimus Blood Levels With Very Low-Dose Cyclosporine Ineffective And Safe In De Novo Renal Transplantation	Mechanism Of Fc Action: Facilitating Cells Enhance The Clonogenicity Of Human Hematopoietic Stem Cells In Vitro	Combining Socs1 Over Expression With Deficiency In Il-1 Signalling Protects Islets From Immune-Mediated Destruction	The Importance Of Defining Warm Ischaemic Time (Wit) When Utilising Controlled Donation After Cardiac Death (Dcd) Lung Donors	The Impact Of Procedural Volume And Other Transplant Hospital Characteristics On The Outcomes Of Kidney Transplantation In The United States	Preventing Kidney Injury By Perfusing Donor Organ With Sirna-Solution	Lessons Learned From 120 Consecutive Living Donor Liver Transplantations For Biliary Atresia In A Single Center	Poor Allostimulatory Function Of Liver Plasmacytoid Dc Is Associated With Pro-Apoptotic Activity And Dependent On Regulatory T Cells
	Hooi Sian Eng	George Mazariegos	Maurizio Salvadori	Mary Jane Elliott	Kate Graham	Bronwyn Levvey	Joseph Kim	Xiufen Zheng	Allan Dante Concejero	Angus Thomson
1620	Simultaneous Kidney Pancreas Transplantation In Patients With Positive Cdcb-Cell And/Or Flow Cytometry Crossmatch	Optn Database Analysis Suggests That The Use Of Dri And Meld As Instruments To Optimize The Donor-Recipient Match In Liver Transplantation	A Phase Ii Randomized Pharmacokinetic (Pk) Study Of Tacrolimus (Tac)-Everolimus (Evl) Combination For Kidney Transplantation (Kt)	Reduced Intensity Conditioning For Allogeneic Hematopoietic Stem Cell Transplant Determines The Kinetics Of Acute Gvhd	Prevention Of Chronic Allograft Rejection By Blocking Ox40 Costimulatory Pathway In Cardiac Transplant Recipients	A Significant Association Between Primary Graft Dysfunction Among Lung, Kidney And Heart Transplant Recipients From The Same Multi-Organ Donor	Genetic Testing In Focal Segmental Glomerulosclerosis (Fsgs) Is Mandatory Before Renal Transplantation: Results From The Ecofts (European Collaborative Fsgs Transplantation Study)	Protection Of Renal Ischemia Injury By Renal Artery Infusion Of Icam-1Sirna	Isolated Liver Transplantation In Children With Cystic Fibrosis - The Anltu Experience	Generation Of Tolerogenic Dendritic Cells For Inhibition Of Allograft Rejection: Mediation Of Suppression By Ilt3, Adrenomedullin, And Apoptosis?
	Raymond Heilman	Alfonso Wolfango Avolio	Julio Pascual	Melinda Kambouris	Hao Wang	Takahiro Oto	Therese Jungraithmayr	Yiping Lu	Scott Nightingale	Peter Terness
1630	Highly Sensitized Renal Transplant Patients: >10 Years Single Centre Experience Without Induction Therapy.	The Application Of Meld Score In Patients Submitted To Liver Transplantation – A Retrospective Analysis Of Survival And The Predictive Factors In The Short And Long Term.	Comparison At One Year Of Interstitial Fibrosis (If) By Automatic Quantification In Renal Transplant Recipients (Rtr) With Cyclosporine (Csa) Discontinuation And Sirolimus (Srl) Introduction	Prophylactic Infusion Of Cmv Specific Cytotoxic T-Lymphocytes Following Allogeneic Haemopoietic Stem Cell Transplantation	Targeting Activated Human Lymphocytes And Monocytes With A New Generation Of Polyclonal Rabbit Anti-Human Leukocyte Antibody (Newralg)	Stepping Up To Take Control: Early Post-Transplant Regulatory T Cell Dynamics In Lung Allograft Recipients	Long-Term Follow-Up Of Solitary Renal Allografts From Pediatric Deceased Donors2 Years Of Age Or Less Transplanted Into Adult Recipients	New Trends In Clinical Cardiac Preservation -  Cold Ischemia Vs. Warm Perfusion- Beneficial Effects For The Endothelium -	Successful Use Of Plasmapheresis Combined With Continuous Renal Replacement Therapy (Crrt) In Treating Children With Acute Hepatic Failure (Ahf) And Acute-On Chronic Hepatic Failure (Achf)	Kidney Sphere Derived Cells Induce The Generation Of Immature Dendritic Cells With A Regulatory Phenotype And Capacity To Inhibit The Alloresponse
	Maarten Christiaans	Ilka Boin	Eric Thervet	Emily Blyth	Zidong Liu	Nicole Mifsud	Francis Wright	Gero Tenderich	George Yanni	Karl Womer
1640	Racial Differences In The Frequencies Of Hla-Specific B Cells		The Incidence Of Delayed Graft Function (Dgf) Following Kidney Transplantations Not Affected By De Novo Everolimus Therapy	Bone Marrow Transplantation Temporarily Improves The Function Of Pancreas In Streptozotocin-Induced Diabetes	A Novel Nf-Kappa B Inhibitor, Dhmeq, Attenuates Arterial Vasculopathy.	Donor Brain Death Inhibits Tolerance Induction In Miniature Swine Lung Transplantation	Pretransplant Monoclonal Gammopathy Of Undetermined Significance (Mgus) As A High Risk Factor For Kidney Transplantation	Polypharmaceutical Survival Kinase Activation Provides Significant Cardiac Protection After Prolonged Hypothermic Storage.	Ten Year Experience With Pre-Emptive Approach To Cmv Infection In Pediatric Liver Transplantation	Dendritic Cells Plus Tgf-Beta1 Differentiated Naïve Cd4+ T Cells But Not Naturalregulatory T Cells Protect Allografts
	Andrea A. Zachary		Christophe Legendre	Mary Jane Elliott	Motohiro Uno	James Allen	Horacio E. Adrogue	Ling Gao	Gregory Smallwood	Manikkam Suthanthiran
1650	It Is No Longer Acceptable To Allocate Deceased Donor (Dd) Kidneys To Sensitised Recipients (Srs) On The Basis Of A Negative T Cell Crossmatch (Tneg Cdc Xm).		Post-Transplant Proteinuria Induced By Everolimus (E). Definition Of Main Features Based On Combined Pathology And Proteomics Approach.			Chronic Gastric Aspiration Leads To Autoimmunity And An Augmented Indirect Alloimmune Response Following Lung Transplantation In Miniature Swine	Renal Transplantation From Hcv-Infected Donors Into Hcv-Infected Recipients: Single Center Experience.	Serum Angiopoietin 1 And 2 Are Elevated In Deceased Brain Dead Donors And Predict Renal Function After Transplantation.
	Paul Trevillian		Elisabetta Bertoni			James Allen	Antonio AMATO	Henri Leuvenink
	Wyeth Sponsored Symposium
1730 - 1900	motor-inhibition - The Science and the Clinical Outcomes
	Chairs: Ross Sheil, Manikkam Suthanthiran
1730	Chairman's Introduction
1735	mTOR - What does it do?
	Michael N. Hall (Switzerland)
1800	The impact of mTOR-inhibition on the development of post-transplant malignancy
	Edward K. Geissler (Germany)
1825	Clinical immunosuppression and the risk of post-transplant malignancy
	Rainer Oberbauer (Austria)
1850	Panel Discussion